Bulk Manufacturer of Controlled Substances Application: Research Triangle Institute, 91948 [2016-30368]
Download as PDF
<![CDATA[
91948
Federal Register / Vol. 81, No. 243 / Monday, December 19, 2016 / Notices
factors, including system and
technology acquisition, expected useful
life of capital equipment, discount
rate(s), and the period over which you
incur costs. Capital and startup costs
include, among other items, computers
and software you purchase to prepare
for collecting information, monitoring,
and record storage facilities. You should
not include estimates for equipment or
services purchased: (a) Before October 1,
1995; (b) to comply with requirements
not associated with the information
collection; (c) for reasons other than to
provide information or keep records for
the Government; or (d) as part of
customary and usual business or private
practices. We will summarize written
responses to this notice and address
them in our submission for OMB
approval. Please note that the comments
submitted in response to this notice are
a matter of public record. We will
include or summarize each comment in
our request to OMB to approve this IC.
As a result of your comments, we will
make any necessary adjustments to the
burden in our submission to OMB.
Public Disclosure Statement: OMB
regulations at 5 CFR part 1320, which
implement provisions of the Paperwork
Reduction Act, 44 U.S.C. 3501–3521,
require that interested members of the
public and affected agencies be given an
opportunity to comment on information
collection and recordkeeping activities
(see 5 CFR 1320.8 (d) and 1320.12(a)).
This notice identifies an information
collection that the BOEM plans to
submit to OMB for approval. The
Paperwork Reduction Act provides that
an agency may not conduct or sponsor
a collection of information unless it
displays a currently valid OMB control
number. Until OMB approves a
collection of information, you are not
obligated to respond.
Public Availability of Comments:
Before including your address, phone
number, email address, or other
personal identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Dated: December 9, 2016.
Deanna Meyer-Pietruszka,
Chief, Office of Policy, Regulation, and
Analysis.
[FR Doc. 2016–30353 Filed 12–16–16; 8:45 am]
BILLING CODE 4310–MR–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Research
Triangle Institute
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
DATES:
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before February 17, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on March
13, 2015, Research Triangle Institute,
Kenneth S. Rehder, Hermann Building,
East Institute Drive, P.O. Box 12194,
Research Triangle Park, North Carolina
27709–2194 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
SUPPLEMENTARY INFORMATION:
Controlled substance
Drug code
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
sradovich on DSK3GMQ082PROD with NOTICES
The company will manufacture
marihuana (7360) and
tetrahydrocannabinols (7370) for use by
their researchers under the above-listed
controlled substances as Active
Pharmaceutical Ingredients (API) for
clinical trials.
In reference to drug code (7370) the
company plans to bulk manufacture a
synthetic tetrahydrocannabinol. No
other activity for this drug code is
authorized for this registration.
Dated: December 3, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–30368 Filed 12–16–16; 8:45 am]
BILLING CODE 4410–09–P
VerDate Sep<11>2014
20:55 Dec 16, 2016
Jkt 241001
Comments are encouraged and
will be accepted for 60 days until
February 17, 2017.
[OMB Number 1121—NEW]
Agency Information Collection
Activities; Proposed Collection
Comments Requested; New Collection:
Death in Custody Reporting Act
Collection
Bureau of Justice Assistance,
Department of Justice.
ACTION: 60-day notice.
AGENCY:
The Department of Justice
(DOJ), Bureau of Justice Assistance will
be submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
PO 00000
Frm 00049
Fmt 4703
Sfmt 4703
I
I
DATES:
DEPARTMENT OF JUSTICE
SUMMARY:
7360
7370
Schedule
If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Chris Casto, Bureau of Justice
Assistance, 810 Seventh Street NW.,
Washington, DC 20531 (email:
DICRAComments@usdoj.gov; telephone:
202–616–6500).
SUPPLEMENTARY INFORMATION: Written
comments and suggestions from the
public and affected agencies concerning
the proposed collection of information
FOR FURTHER INFORMATION CONTACT:
E:\FR\FM\19DEN1.SGM
19DEN1
]]>Agencies
[Federal Register Volume 81, Number 243 (Monday, December 19, 2016)]
[Notices]
[Page 91948]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-30368]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Research
Triangle Institute
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before February 17, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on March
13, 2015, Research Triangle Institute, Kenneth S. Rehder, Hermann
Building, East Institute Drive, P.O. Box 12194, Research Triangle Park,
North Carolina 27709-2194 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Marihuana....................... 7360 I
Tetrahydrocannabinols........... 7370 I
------------------------------------------------------------------------
The company will manufacture marihuana (7360) and
tetrahydrocannabinols (7370) for use by their researchers under the
above-listed controlled substances as Active Pharmaceutical Ingredients
(API) for clinical trials.
In reference to drug code (7370) the company plans to bulk
manufacture a synthetic tetrahydrocannabinol. No other activity for
this drug code is authorized for this registration.
Dated: December 3, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-30368 Filed 12-16-16; 8:45 am]
BILLING CODE 4410-09-P
